CFC1B
gene geneOn this page
Summary
CFC1B (cryptic, EGF-CFC family member 1B, HGNC:33983) is a protein-coding gene on chromosome 2q21.1, encoding Cryptic family protein 1B (P0CG36).
Predicted to enable activin receptor binding activity and nodal binding activity. Predicted to be involved in circulatory system development; nodal signaling pathway; and regionalization. Predicted to act upstream of or within several processes, including heart development; left lung morphogenesis; and spleen development. Predicted to be active in cell surface and extracellular region. Implicated in tetralogy of Fallot and visceral heterotaxy.
Source: NCBI Gene 653275 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001079530
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33983 |
| Approved symbol | CFC1B |
| Name | cryptic, EGF-CFC family member 1B |
| Location | 2q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000152093 |
| Ensembl biotype | protein_coding |
| Entrez | 653275 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000281882, ENST00000619050, ENST00000620207
RefSeq mRNA: 1 — MANE Select: NM_001079530
NM_001079530
CCDS: CCDS33286
Canonical transcript exons
ENST00000281882 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002449422 | 130522790 | 130522904 |
| ENSE00002452682 | 130521957 | 130522130 |
| ENSE00002480432 | 130527696 | 130528603 |
| ENSE00002490771 | 130523169 | 130523278 |
| ENSE00002515225 | 130521813 | 130521862 |
| ENSE00003847123 | 130521222 | 130521507 |
Expression profiles
Bgee: expression breadth broad, 54 present calls, max score 81.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4004 / max 84.4732, expressed in 59 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 22515 | 0.1717 | 38 |
| 202389 | 0.1368 | 41 |
| 22516 | 0.0490 | 29 |
| 202390 | 0.0429 | 20 |
Top tissues by expression
124 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.22 | silver quality |
| islet of Langerhans | UBERON:0000006 | 47.85 | gold quality |
| ventricular zone | UBERON:0003053 | 43.39 | gold quality |
| prefrontal cortex | UBERON:0000451 | 41.30 | gold quality |
| granulocyte | CL:0000094 | 41.18 | gold quality |
| rectum | UBERON:0001052 | 40.29 | gold quality |
| bone marrow cell | CL:0002092 | 38.29 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.83 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 37.24 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| apex of heart | UBERON:0002098 | 36.55 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 36.15 | silver quality |
| sural nerve | UBERON:0015488 | 35.67 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.55 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| pancreas | UBERON:0001264 | 35.28 | gold quality |
| muscle tissue | UBERON:0002385 | 34.24 | gold quality |
| bone marrow | UBERON:0002371 | 33.97 | gold quality |
| gall bladder | UBERON:0002110 | 33.78 | gold quality |
| duodenum | UBERON:0002114 | 33.59 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| frontal cortex | UBERON:0001870 | 32.08 | gold quality |
| leukocyte | CL:0000738 | 31.92 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 31.88 | gold quality |
| monocyte | CL:0000576 | 31.56 | gold quality |
| urinary bladder | UBERON:0001255 | 31.16 | silver quality |
| liver | UBERON:0002107 | 30.86 | gold quality |
| right adrenal gland | UBERON:0001233 | 30.84 | gold quality |
| tonsil | UBERON:0002372 | 30.05 | gold quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-5061 | yes | 2621.68 |
| E-MTAB-9388 | yes | 530.75 |
| E-HCAD-56 | yes | 277.52 |
| E-GEOD-83139 | yes | 10.57 |
| E-ANND-3 | yes | 4.49 |
| E-HCAD-31 | no | 30.60 |
| E-MTAB-7303 | no | 25.70 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cfc1 | ENSMUSG00000026124 |
| rattus_norvegicus | Cfc1 | ENSRNOG00000042646 |
Paralogs (5): CFC1 (ENSG00000136698), EGFL7 (ENSG00000172889), CRIPTO3 (ENSG00000225366), CRIPTO (ENSG00000241186), EGFL8 (ENSG00000241404)
Protein
Protein identifiers
Cryptic family protein 1B — P0CG36 (reviewed: P0CG36)
All UniProt accessions (3): P0CG36, A0A087WWE4, A0A087X0G3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the EGF-CFC (Cripto-1/FRL1/Cryptic) family.
RefSeq proteins (1): NP_001072998* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000742 | EGF | Domain |
| IPR019011 | Cryptic/Cripto_CFC-dom | Domain |
Pfam: PF09443
UniProt features (7 total): disulfide bond 3, signal peptide 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG36-F1 | 63.99 | 0.23 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 90–97, 91–103, 105–114
Glycosylation sites (1): 52
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
GOCC_CELL_SURFACE, GOBP_SPECIFICATION_OF_SYMMETRY, GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION, GOBP_GASTRULATION, GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY, GOBP_EMBRYO_DEVELOPMENT, GOMF_SIGNALING_RECEPTOR_BINDING, GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT, GOBP_EMBRYONIC_MORPHOGENESIS, GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, MIKKELSEN_ES_ICP_WITH_H3K4ME3, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A, GOBP_NODAL_SIGNALING_PATHWAY, GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY
GO Biological Process (7): blood vessel development (GO:0001568), determination of left/right symmetry (GO:0007368), gastrulation (GO:0007369), heart development (GO:0007507), anterior/posterior pattern specification (GO:0009952), nodal signaling pathway (GO:0038092), signal transduction (GO:0007165)
GO Molecular Function (2): nodal binding (GO:0038100), activin receptor binding (GO:0070697)
GO Cellular Component (2): extracellular region (GO:0005576), cell surface (GO:0009986)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| vasculature development | 1 |
| anatomical structure development | 1 |
| determination of bilateral symmetry | 1 |
| left/right pattern formation | 1 |
| ectoderm formation | 1 |
| endoderm formation | 1 |
| mesoderm formation | 1 |
| embryonic morphogenesis | 1 |
| animal organ development | 1 |
| circulatory system development | 1 |
| regionalization | 1 |
| activin receptor signaling pathway | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| protein binding | 1 |
| transmembrane receptor protein serine/threonine kinase binding | 1 |
Protein interactions and networks
STRING
356 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFC1B | ANKUB1 | A6NFN9 | 507 |
| CFC1B | UPK3BL1 | B0FP48 | 411 |
| CFC1B | MMACHC | Q9Y4U1 | 369 |
| CFC1B | EVC2 | Q86UK5 | 358 |
| CFC1B | CMTM8 | Q8IZV2 | 318 |
| CFC1B | HEMGN | Q9BXL5 | 312 |
| CFC1B | MPZL3 | Q6UWV2 | 306 |
| CFC1B | ZSCAN18 | Q8TBC5 | 300 |
| CFC1B | SYT8 | Q8NBV8 | 293 |
| CFC1B | RBP5 | P82980 | 280 |
| CFC1B | EGF | P01133 | 279 |
| CFC1B | RNF152 | Q8N8N0 | 277 |
| CFC1B | B3GNT7 | Q8NFL0 | 274 |
| CFC1B | ARHGAP42 | A6NI28 | 271 |
| CFC1B | TBX20 | Q9UMR3 | 269 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2A699, A2BD09, A5D7T4, A8MVW0, B0BN44, O77681, O88829, P0CG36, P0CG37, P15907, P51693, P59383, P61132, P70277, P97325, Q03157, Q07105, Q11203, Q3UPI1, Q3UY90, Q5K027, Q5QQ37, Q64685, Q66NC0, Q68BL7, Q6P7B4, Q6UWH4, Q701R2, Q701R3, Q701R4, Q70D51, Q766D5, Q76K27, Q76KP1, Q80WV3, Q866Y3, Q86VZ4, Q8BHP7, Q8CB67, Q8VCS0
Diamond homologs: P0CG36, P0CG37, P13385, P51864, P51865, P97766, Q9I8Q3, O88277, Q5F226, A0A2K5V015, Q5R6R1, Q5T1H1, O97507, Q20911
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
728 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:130521508:G:GA | donor_loss | 1.0000 |
| 2:130521509:T:G | donor_loss | 1.0000 |
| 2:130521863:G:GG | donor_gain | 1.0000 |
| 2:130521953:A:AG | acceptor_gain | 1.0000 |
| 2:130521953:AAAG:A | acceptor_gain | 1.0000 |
| 2:130521954:AAG:A | acceptor_gain | 1.0000 |
| 2:130521955:A:AC | acceptor_loss | 1.0000 |
| 2:130521955:A:AG | acceptor_gain | 1.0000 |
| 2:130521955:AG:A | acceptor_gain | 1.0000 |
| 2:130521956:G:A | acceptor_gain | 1.0000 |
| 2:130521956:G:GG | acceptor_gain | 1.0000 |
| 2:130521956:GGCT:G | acceptor_gain | 1.0000 |
| 2:130522127:GAGG:G | donor_gain | 1.0000 |
| 2:130522129:GG:G | donor_gain | 1.0000 |
| 2:130522130:GG:G | donor_gain | 1.0000 |
| 2:130522131:GTAA:G | donor_loss | 1.0000 |
| 2:130522132:T:A | donor_loss | 1.0000 |
| 2:130522903:AGGT:A | donor_loss | 1.0000 |
| 2:130522904:GG:G | donor_loss | 1.0000 |
| 2:130522905:G:GA | donor_loss | 1.0000 |
| 2:130521508:G:GG | donor_gain | 0.9900 |
| 2:130521954:A:G | acceptor_gain | 0.9900 |
| 2:130521956:GGC:G | acceptor_gain | 0.9900 |
| 2:130521956:GGCTA:G | acceptor_gain | 0.9900 |
| 2:130522131:G:GG | donor_gain | 0.9900 |
| 2:130522789:GGTGC:G | acceptor_gain | 0.9900 |
| 2:130523167:A:AG | acceptor_gain | 0.9900 |
| 2:130523168:G:GG | acceptor_gain | 0.9900 |
| 2:130523168:GT:G | acceptor_gain | 0.9900 |
| 2:130521503:GTCAG:G | donor_gain | 0.9800 |
AlphaMissense
1437 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:130523199:G:C | W131C | 0.994 |
| 2:130523199:G:T | W131C | 0.994 |
| 2:130522846:T:C | F102L | 0.992 |
| 2:130522848:C:A | F102L | 0.992 |
| 2:130522848:C:G | F102L | 0.992 |
| 2:130522868:T:G | F109C | 0.991 |
| 2:130522847:T:G | F102C | 0.990 |
| 2:130522867:T:C | F109L | 0.990 |
| 2:130522869:C:A | F109L | 0.990 |
| 2:130522869:C:G | F109L | 0.990 |
| 2:130522883:G:A | C114Y | 0.982 |
| 2:130522873:G:T | G111C | 0.981 |
| 2:130522882:T:A | C114S | 0.976 |
| 2:130522883:G:C | C114S | 0.976 |
| 2:130522868:T:C | F109S | 0.972 |
| 2:130522820:A:T | N93I | 0.971 |
| 2:130522883:G:T | C114F | 0.970 |
| 2:130522850:G:A | C103Y | 0.969 |
| 2:130522884:C:G | C114W | 0.968 |
| 2:130523197:T:A | W131R | 0.967 |
| 2:130523197:T:C | W131R | 0.967 |
| 2:130523233:T:C | F143L | 0.966 |
| 2:130523235:C:A | F143L | 0.966 |
| 2:130523235:C:G | F143L | 0.966 |
| 2:130522855:T:A | C105S | 0.961 |
| 2:130522856:G:C | C105S | 0.961 |
| 2:130522874:G:T | G111V | 0.961 |
| 2:130523173:T:A | C123S | 0.961 |
| 2:130523174:G:C | C123S | 0.961 |
| 2:130523227:T:A | C141S | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1003875767 (2:130521779 T>A), RS1011692924 (2:130525363 G>C), RS1011806026 (2:130523493 T>C), RS1021829998 (2:130523588 G>A), RS1021839821 (2:130525480 C>CA), RS1023044275 (2:130526207 CACCA>C), RS1029547454 (2:130522516 G>A), RS1035946165 (2:130528939 T>C), RS1036070093 (2:130525711 T>G), RS1040824201 (2:130521797 T>C), RS1041086287 (2:130524439 C>T), RS1048325318 (2:130520787 A>G), RS1048378035 (2:130524177 C>G), RS1049976385 (2:130527557 G>A,C), RS1055994762 (2:130520419 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.